Healthcare Sector Stocks
The Healthcare sector has a total of 1053 stocks, with a combined market cap of $8.97 trillion, total revenue of $4.62 trillion and a weighted average PE ratio of 43.96.
Market Cap
8.97T
Revenue
4.62T
Profits
204.03B
PE Ratio
43.96
Profit Margin
4.42%
Dividend Yield
0.39%
1053 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.00T | -2.16% | 2,356,101 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 614.79B | -0.48% | 4,899,566 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 434.08B | -2.09% | 5,355,460 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 377.23B | 0.24% | 2,250,546 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 316.73B | -1.51% | 7,768,828 | 65.77B |
| 6 | NVS | Novartis AG | 297.39B | -1.41% | 1,463,792 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 239.46B | -6.00% | 15,198,150 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 212.69B | 0.16% | 1,195,094 | 46.34B |
| 9 | NVO | Novo Nordisk A/S | 205.77B | - | 10,379,788 | 50.57B |
| 10 | AMGN | Amgen Inc. | 204.55B | -1.60% | 2,233,178 | 37.22B |
| 11 | ABT | Abbott Laboratories | 185.69B | 1.52% | 4,428,419 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 162.84B | 0.73% | 4,910,730 | 29.74B |
| 13 | PFE | Pfizer Inc. | 142.94B | 0.28% | 31,946,959 | 63.32B |
| 14 | DHR | Danaher Corporation | 139.09B | 1.47% | 2,158,806 | 25.11B |
| 15 | CVS | CVS Health Corporation | 134.41B | 0.87% | 3,942,041 | 405.62B |
| 16 | BMY | Bristol-Myers Squibb Company | 133.74B | 0.24% | 22,647,853 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 132.41B | 6.08% | 2,720,884 | 11.03B |
| 18 | SYK | Stryker Corporation | 131.14B | 4.97% | 1,954,404 | 25.84B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 119.34B | -1.44% | 965,728 | 12.22B |
| 20 | MDT | Medtronic plc | 111.02B | 1.57% | 5,065,470 | 36.36B |
| 21 | GSK | GSK plc | 104.18B | -0.27% | 4,016,284 | 44.05B |
| 22 | SNY | Sanofi | 102.70B | -0.29% | 2,396,825 | 55.89B |
| 23 | MCK | McKesson Corporation | 97.09B | -3.15% | 769,870 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 87.98B | 0.94% | 851,283 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 83.17B | 2.04% | 720,170 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 75.87B | -0.37% | 597,153 | 15.53B |
| 27 | CI | The Cigna Group | 74.77B | 1.40% | 1,293,365 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 72.13B | 3.85% | 15,008,753 | 21.00B |
| 29 | COR | Cencora, Inc. | 59.96B | -1.01% | 1,035,827 | 328.68B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 55.08B | -1.40% | 2,625,683 | 28.42B |
| 31 | CAH | Cardinal Health, Inc. | 54.99B | 2.07% | 1,366,763 | 250.74B |
| 32 | ARGX | argenx SE | 53.60B | -2.96% | 205,266 | 5.32B |
| 33 | MDLN | Medline Inc. | 53.24B | 3.18% | 3,023,736 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 51.01B | 2.92% | 2,757,118 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 46.87B | 2.71% | 1,194,008 | 22.23B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.78B | 1.53% | 965,827 | 4.45B |
| 37 | HUM | Humana Inc. | 44.61B | 2.10% | 918,039 | 145.68B |
| 38 | HLN | Haleon plc | 43.08B | -0.66% | 12,054,149 | 14.80B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 40.19B | -1.50% | 3,812,894 | 17.32B |
| 40 | A | Agilent Technologies, Inc. | 39.57B | 1.26% | 1,148,804 | 7.23B |
| 41 | NTRA | Natera, Inc. | 38.77B | 1.09% | 907,320 | 2.50B |
| 42 | RVMD | Revolution Medicines, Inc. | 38.73B | -2.85% | 1,106,082 | - |
| 43 | IQV | IQVIA Holdings Inc. | 38.56B | -0.32% | 1,200,290 | 16.98B |
| 44 | WAT | Waters Corporation | 36.78B | -0.71% | 889,244 | 3.77B |
| 45 | ONC | BeOne Medicines AG | 34.86B | -0.77% | 281,587 | 5.74B |
| 46 | ALC | Alcon Inc. | 34.03B | 1.68% | 1,657,337 | 10.63B |
| 47 | VEEV | Veeva Systems Inc. | 33.46B | 1.09% | 2,131,921 | 3.32B |
| 48 | DXCM | DexCom, Inc. | 33.05B | 4.96% | 6,940,985 | 4.97B |
| 49 | RPRX | Royalty Pharma plc | 32.86B | -2.33% | 1,816,021 | 2.44B |
| 50 | ZTS | Zoetis Inc. | 32.38B | -0.08% | 3,993,401 | 9.53B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 31.54B | 2.65% | 2,965,962 | 21.27B |
| 52 | CNC | Centene Corporation | 31.46B | 2.36% | 5,401,033 | 180.30B |
| 53 | RMD | ResMed Inc. | 31.04B | 2.00% | 1,015,297 | 5.54B |
| 54 | ILMN | Illumina, Inc. | 29.94B | -3.33% | 2,030,481 | 4.49B |
| 55 | BIIB | Biogen Inc. | 29.80B | -0.64% | 594,132 | 10.03B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.48B | 7.20% | 2,516,342 | 4.80B |
| 57 | MTD | Mettler-Toledo International Inc. | 28.91B | 1.88% | 136,387 | 4.13B |
| 58 | DGX | Quest Diagnostics Incorporated | 25.66B | -0.21% | 527,348 | 11.56B |
| 59 | PHG | Koninklijke Philips N.V. | 25.54B | -0.40% | 921,209 | 20.18B |
| 60 | LH | Labcorp Holdings Inc. | 24.92B | -0.36% | 479,276 | 14.35B |
| 61 | WST | West Pharmaceutical Services, Inc. | 24.47B | 1.97% | 412,584 | 3.33B |
| 62 | INCY | Incyte Corporation | 23.97B | -1.06% | 918,046 | 5.82B |
| 63 | ROIV | Roivant Sciences Ltd. | 23.93B | -1.89% | 4,422,885 | 8.26M |
| 64 | BNTX | BioNTech SE | 23.33B | 1.87% | 902,162 | 3.23B |
| 65 | STE | STERIS plc | 22.64B | 1.72% | 514,230 | 5.94B |
| 66 | MRNA | Moderna, Inc. | 22.07B | 0.84% | 4,049,649 | 2.23B |
| 67 | UTHR | United Therapeutics Corporation | 21.89B | -0.38% | 316,820 | 3.17B |
| 68 | GH | Guardant Health, Inc. | 21.47B | -1.22% | 1,424,103 | 1.18B |
| 69 | INSM | Insmed Incorporated | 21.32B | -0.26% | 2,961,080 | 819.56M |
| 70 | VTRS | Viatris Inc. | 20.54B | 0.46% | 6,612,133 | 14.56B |
| 71 | THC | Tenet Healthcare Corporation | 20.14B | -1.83% | 856,791 | 21.81B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.75B | 3.18% | 1,447,751 | 8.41B |
| 73 | GMAB | Genmab A/S | 17.44B | -0.73% | 1,557,359 | 3.90B |
| 74 | NBIX | Neurocrine Biosciences, Inc. | 16.94B | -0.08% | 1,081,964 | 3.37B |
| 75 | ASND | Ascendis Pharma A/S | 16.07B | -0.03% | 410,784 | 998.25M |
| 76 | MEDP | Medpace Holdings, Inc. | 16.06B | -0.32% | 189,331 | 2.78B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.81B | -0.45% | 850,116 | 4.44B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 15.66B | 0.04% | 915,219 | 579.96M |
| 79 | SOLV | Solventum Corporation | 15.27B | 3.17% | 981,602 | 8.26B |
| 80 | DVA | DaVita Inc. | 15.01B | -2.60% | 1,073,804 | 13.84B |
| 81 | BAX | Baxter International Inc. | 14.50B | 7.19% | 7,553,699 | 11.47B |
| 82 | COO | The Cooper Companies, Inc. | 14.47B | 2.60% | 1,106,148 | 4.23B |
| 83 | EXEL | Exelixis, Inc. | 13.84B | 3.86% | 3,320,707 | 2.38B |
| 84 | FMS | Fresenius Medical Care AG | 13.68B | -1.23% | 1,309,027 | 22.32B |
| 85 | SNN | Smith & Nephew plc | 13.52B | 2.11% | 1,358,572 | 6.16B |
| 86 | RVTY | Revvity, Inc. | 12.90B | 2.78% | 1,855,313 | 2.90B |
| 87 | ELAN | Elanco Animal Health Incorporated | 12.80B | -2.79% | 4,158,139 | 4.89B |
| 88 | BTSG | BrightSpring Health Services, Inc. | 12.79B | 2.19% | 3,615,563 | 14.37B |
| 89 | PEN | Penumbra, Inc. | 12.73B | 0.63% | 225,428 | 1.50B |
| 90 | ALGN | Align Technology, Inc. | 12.39B | 2.31% | 624,294 | 4.14B |
| 91 | ICLR | ICON Public Limited Company | 12.25B | -2.94% | 879,533 | 8.29B |
| 92 | CORT | Corcept Therapeutics Incorporated | 12.25B | -1.04% | 1,260,775 | 830.81M |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.10B | 1.44% | 1,015,082 | 622.01M |
| 94 | PODD | Insulet Corporation | 11.75B | 2.63% | 1,074,117 | 2.90B |
| 95 | BMRN | BioMarin Pharmaceutical Inc. | 11.59B | -0.12% | 1,136,394 | 3.24B |
| 96 | TECH | Bio-Techne Corporation | 11.24B | 0.04% | 2,743,690 | 1.21B |
| 97 | EHC | Encompass Health Corporation | 11.20B | 1.62% | 763,153 | 6.07B |
| 98 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.15B | 3.24% | 298,087 | 1.28B |
| 99 | CRL | Charles River Laboratories International, Inc. | 11.10B | -0.89% | 459,286 | 4.03B |
| 100 | GMED | Globus Medical, Inc. | 11.04B | 3.21% | 638,291 | 3.10B |
| 101 | AXSM | Axsome Therapeutics, Inc. | 10.90B | -2.80% | 780,076 | 708.24M |
| 102 | ABVX | ABIVAX Société Anonyme | 10.54B | -0.28% | 869,868 | 5.67M |
| 103 | SMMT | Summit Therapeutics Inc. | 10.43B | 0.38% | 2,527,618 | - |
| 104 | CYTK | Cytokinetics, Incorporated | 10.40B | -0.65% | 1,729,413 | 105.82M |
| 105 | ENSG | The Ensign Group, Inc. | 10.25B | -0.47% | 195,908 | 5.49B |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.22B | 1.81% | 2,741,436 | 3.50B |
| 107 | UHS | Universal Health Services, Inc. | 10.22B | 0.24% | 701,023 | 18.11B |
| 108 | GKOS | Glaukos Corporation | 10.16B | 3.35% | 816,605 | 612.84M |
| 109 | MOH | Molina Healthcare, Inc. | 10.15B | -0.43% | 477,515 | 42.47B |
| 110 | APGE | Apogee Therapeutics, Inc. | 10.07B | - | 865,503 | - |
| 111 | HSIC | Henry Schein, Inc. | 9.86B | 0.97% | 1,562,705 | 13.38B |
| 112 | BRKR | Bruker Corporation | 9.79B | 2.39% | 1,870,152 | 3.46B |
| 113 | HALO | Halozyme Therapeutics, Inc. | 9.76B | -0.30% | 842,972 | 1.51B |
| 114 | OSCR | Oscar Health, Inc. | 9.26B | -1.51% | 2,587,566 | 13.30B |
| 115 | KRYS | Krystal Biotech, Inc. | 9.24B | -8.15% | 1,014,888 | 440.48M |
| 116 | AVTR | Avantor, Inc. | 9.22B | -1.12% | 6,844,274 | 6.56B |
| 117 | IONS | Ionis Pharmaceuticals, Inc. | 9.04B | 5.12% | 1,982,496 | 874.09M |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 8.97B | 2.93% | 156,867 | 2.59B |
| 119 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.83B | 0.28% | 1,134,204 | 18.07M |
| 120 | QGEN | Qiagen N.V. | 8.75B | 2.21% | 1,586,054 | 2.10B |
| 121 | HQY | HealthEquity, Inc. | 8.72B | 3.68% | 682,088 | 1.34B |
| 122 | ATR | AptarGroup, Inc. | 8.66B | 1.63% | 462,704 | 3.93B |
| 123 | PRAX | Praxis Precision Medicines, Inc. | 8.54B | -0.44% | 253,411 | 7.46M |
| 124 | PTGX | Protagonist Therapeutics, Inc. | 8.48B | -3.48% | 275,977 | 74.06M |
| 125 | SYRE | Spyre Therapeutics, Inc. | 8.40B | -2.86% | 625,445 | - |
| 126 | ALKS | Alkermes plc | 8.35B | 1.63% | 1,210,043 | 1.67B |
| 127 | TEM | Tempus AI, Inc. | 8.31B | 5.04% | 4,634,148 | 1.43B |
| 128 | RGEN | Repligen Corporation | 8.30B | 4.25% | 769,656 | 785.10M |
| 129 | KYMR | Kymera Therapeutics, Inc. | 8.27B | -2.80% | 514,528 | 51.48M |
| 130 | IMVT | Immunovant, Inc. | 7.96B | -0.18% | 508,437 | - |
| 131 | PCVX | Vaxcyte, Inc. | 7.74B | -0.94% | 522,574 | - |
| 132 | IBRX | ImmunityBio, Inc. | 7.53B | 0.21% | 6,753,438 | 140.98M |
| 133 | LQDA | Liquidia Corporation | 7.46B | -0.30% | 898,732 | 288.07M |
| 134 | HIMS | Hims & Hers Health, Inc. | 7.15B | 11.20% | 12,415,831 | 2.37B |
| 135 | PACS | PACS Group, Inc. | 7.13B | -2.06% | 887,940 | 5.43B |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.09B | 4.20% | 701,237 | 217.17M |
| 137 | CHE | Chemed Corporation | 7.02B | 1.39% | 152,512 | 2.60B |
| 138 | GRFS | Grifols, S.A. | 6.84B | -0.38% | 353,303 | 8.48B |
| 139 | COGT | Cogent Biosciences, Inc. | 6.67B | 0.28% | 1,027,473 | - |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.58B | 1.49% | 7,558,395 | 1.55B |
| 141 | TGTX | TG Therapeutics, Inc. | 6.54B | -11.30% | 5,790,840 | 799.54M |
| 142 | MIRM | Mirum Pharmaceuticals, Inc. | 6.37B | -1.43% | 356,232 | 569.61M |
| 143 | BLLN | BillionToOne, Inc. | 6.31B | -1.06% | 573,257 | 354.54M |
| 144 | TWST | Twist Bioscience Corporation | 6.25B | 9.63% | 2,521,170 | 431.80M |
| 145 | TFX | Teleflex Incorporated | 6.20B | 2.36% | 796,732 | 2.13B |
| 146 | ERAS | Erasca, Inc. | 6.19B | -1.76% | 2,066,044 | - |
| 147 | CGON | CG Oncology, Inc. | 6.10B | -2.87% | 429,903 | 5.07M |
| 148 | BLTE | Belite Bio, Inc | 6.06B | -2.91% | 165,785 | - |
| 149 | XENE | Xenon Pharmaceuticals Inc. | 6.04B | -0.36% | 352,909 | 7.50M |
| 150 | AMRX | Amneal Pharmaceuticals, Inc. | 6.03B | 3.11% | 1,721,434 | 3.12B |
| 151 | TXG | 10x Genomics, Inc. | 6.02B | 0.28% | 2,126,605 | 638.78M |
| 152 | HNGE | Hinge Health, Inc. | 6.00B | 3.87% | 1,372,955 | 646.34M |
| 153 | BLCO | Bausch + Lomb Corporation | 5.95B | -1.42% | 271,844 | 5.32B |
| 154 | DNTH | Dianthus Therapeutics, Inc. | 5.82B | -0.42% | 628,043 | 1.34M |
| 155 | LGND | Ligand Pharmaceuticals Incorporated | 5.79B | 1.70% | 138,554 | 274.48M |
| 156 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.73B | -1.29% | 583,024 | 840.85M |
| 157 | ORKA | Oruka Therapeutics, Inc. | 5.70B | -2.01% | 615,314 | - |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.69B | 0.29% | 1,039,075 | 1.01B |
| 159 | STVN | Stevanato Group S.p.A. | 5.64B | 4.08% | 630,246 | 1.39B |
| 160 | DFTX | Definium Therapeutics, Inc. | 5.56B | -3.77% | 1,506,597 | - |
| 161 | SRRK | Scholar Rock Holding Corporation | 5.52B | -2.55% | 572,288 | - |
| 162 | MMED | MiniMed Group, Inc. | 5.33B | 5.21% | 780,446 | 3.10B |
| 163 | RDNT | RadNet, Inc. | 5.26B | 4.94% | 429,865 | 2.14B |
| 164 | SHC | Sotera Health Company | 5.13B | 0.67% | 1,075,233 | 1.19B |
| 165 | TVTX | Travere Therapeutics, Inc. | 5.12B | -1.57% | 1,468,052 | 536.20M |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.11B | 0.59% | 1,223,495 | 1.58B |
| 167 | CRSP | CRISPR Therapeutics AG | 4.88B | 3.33% | 1,134,837 | 4.10M |
| 168 | DYN | Dyne Therapeutics, Inc. | 4.71B | 0.12% | 1,719,319 | - |
| 169 | CAI | Caris Life Sciences, Inc. | 4.58B | 3.45% | 3,490,356 | 907.29M |
| 170 | INDV | Indivior Pharmaceuticals, Inc. | 4.58B | -6.15% | 5,694,574 | 1.33B |
| 171 | LIVN | LivaNova PLC | 4.51B | 2.35% | 468,135 | 1.43B |
| 172 | NVST | Envista Holdings Corporation | 4.45B | 0.15% | 2,246,789 | 2.81B |
| 173 | ACAD | ACADIA Pharmaceuticals Inc. | 4.39B | -0.85% | 902,796 | 1.10B |
| 174 | WAY | Waystar Holding Corp. | 4.35B | 7.53% | 2,594,572 | 1.21B |
| 175 | ICUI | ICU Medical, Inc. | 4.32B | 2.53% | 465,398 | 2.16B |
| 176 | PBLS | Parabilis Medicines, Inc. | 4.31B | -0.29% | 631,796 | - |
| 177 | CELC | Celcuity Inc. | 4.27B | 1.34% | 405,439 | - |
| 178 | ITGR | Integer Holdings Corporation | 4.23B | 2.67% | 11,675,145 | 1.86B |
| 179 | MANE | Veradermics, Incorporated | 4.21B | -4.08% | 2,546,395 | - |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 4.12B | -0.34% | 397,111 | - |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.09B | -0.27% | 1,090,653 | 10.68M |
| 182 | LFST | LifeStance Health Group, Inc. | 4.08B | 0.38% | 2,408,034 | 1.49B |
| 183 | ELVN | Enliven Therapeutics, Inc. | 4.07B | 6.42% | 2,518,430 | - |
| 184 | CON | Concentra Group Holdings Parent, Inc. | 4.07B | 0.51% | 349,390 | 2.23B |
| 185 | IRTC | iRhythm Holdings, Inc. | 4.06B | 5.41% | 457,170 | 787.85M |
| 186 | HAE | Haemonetics Corporation | 3.96B | 1.86% | 883,062 | 1.33B |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.93B | 0.07% | 1,482,072 | 56.99M |
| 188 | DOCS | Doximity, Inc. | 3.92B | 4.30% | 2,278,572 | 644.86M |
| 189 | VKTX | Viking Therapeutics, Inc. | 3.81B | 3.02% | 1,285,207 | - |
| 190 | ADPT | Adaptive Biotechnologies Corporation | 3.70B | 2.97% | 1,752,633 | 308.08M |
| 191 | DNLI | Denali Therapeutics Inc. | 3.68B | 0.61% | 622,744 | - |
| 192 | LEGN | Legend Biotech Corporation | 3.67B | 2.18% | 1,224,309 | 1.14B |
| 193 | VCYT | Veracyte, Inc. | 3.64B | -2.18% | 1,487,829 | 561.90M |
| 194 | OGN | Organon & Co. | 3.56B | 0.15% | 1,270,188 | 6.13B |
| 195 | OPCH | Option Care Health, Inc. | 3.54B | 2.74% | 1,888,642 | 5.69B |
| 196 | NHC | National HealthCare Corporation | 3.50B | -0.99% | 87,147 | 1.53B |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.49B | -1.53% | 604,344 | 236.00M |
| 198 | WRBY | Warby Parker Inc. | 3.47B | 5.81% | 2,232,492 | 890.57M |
| 199 | BKD | Brookdale Senior Living Inc. | 3.45B | -1.10% | 4,254,007 | 3.00B |
| 200 | GPCR | Structure Therapeutics Inc. | 3.44B | 0.60% | 216,456 | - |
| 201 | TLX | Telix Pharmaceuticals Limited | 3.40B | 1.42% | 113,658 | 803.79M |
| 202 | IDYA | IDEAYA Biosciences, Inc. | 3.37B | -0.08% | 219,003 | 225.27M |
| 203 | ALMS | Alumis Inc. | 3.32B | -7.68% | 1,093,490 | 8.40M |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.24B | -3.61% | 858,143 | 415.62M |
| 205 | NAMS | NewAmsterdam Pharma Company N.V. | 3.20B | -1.48% | 815,994 | 22.57M |
| 206 | MBX | MBX Biosciences, Inc. | 3.10B | -1.06% | 299,789 | - |
| 207 | RGC | Regencell Bioscience Holdings Limited | 3.06B | - | 262,616 | - |
| 208 | QURE | uniQure N.V. | 3.05B | 0.94% | 890,202 | 18.67M |
| 209 | GRAL | GRAIL, Inc. | 3.02B | 2.73% | 276,305 | 156.12M |
| 210 | PRVA | Privia Health Group, Inc. | 3.00B | 0.63% | 358,920 | 2.25B |
| 211 | ALHC | Alignment Healthcare, Inc. | 3.00B | -2.56% | 9,949,470 | 4.58B |
| 212 | CLDX | Celldex Therapeutics, Inc. | 2.97B | -0.68% | 1,384,555 | 865.00K |
| 213 | IRON | Disc Medicine, Inc. | 2.92B | -1.25% | 136,070 | - |
| 214 | ACHC | Acadia Healthcare Company, Inc. | 2.84B | 2.94% | 1,903,105 | 3.37B |
| 215 | XRAY | DENTSPLY SIRONA Inc. | 2.82B | 5.31% | 6,343,890 | 3.68B |
| 216 | TMDX | TransMedics Group, Inc. | 2.82B | 6.59% | 1,288,196 | 635.89M |
| 217 | ESTA | Establishment Labs Holdings Inc. | 2.74B | 0.56% | 746,153 | 229.58M |
| 218 | TARS | Tarsus Pharmaceuticals, Inc. | 2.67B | 5.25% | 618,463 | 535.08M |
| 219 | SUPN | Supernus Pharmaceuticals, Inc. | 2.67B | 3.04% | 3,617,296 | 830.44M |
| 220 | ATAI | AtaiBeckley Inc. | 2.65B | -0.14% | 13,479,363 | 3.49M |
| 221 | BHC | Bausch Health Companies Inc. | 2.63B | 1.89% | 7,394,690 | 10.85B |
| 222 | PLSE | Pulse Biosciences, Inc. | 2.62B | 7.83% | 253,523 | 751.00K |
| 223 | NEOG | Neogen Corporation | 2.59B | -1.41% | 3,850,974 | 870.40M |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.59B | 3.34% | 160,715 | 1.46B |
| 225 | BEAM | Beam Therapeutics Inc. | 2.59B | 1.82% | 981,073 | 164.01M |
| 226 | IMNM | Immunome, Inc. | 2.58B | 0.09% | 890,173 | 4.02M |
| 227 | TRVI | Trevi Therapeutics, Inc. | 2.55B | -1.42% | 926,070 | - |
| 228 | KOD | Kodiak Sciences Inc. | 2.49B | -4.18% | 402,139 | - |
| 229 | PGNY | Progyny, Inc. | 2.47B | 1.12% | 481,071 | 1.29B |
| 230 | PBH | Prestige Consumer Healthcare Inc. | 2.47B | 3.62% | 635,026 | 1.09B |
| 231 | RARE | Ultragenyx Pharmaceutical Inc. | 2.46B | 0.76% | 1,539,643 | 670.00M |
| 232 | AXGN | Axogen, Inc. | 2.46B | 8.32% | 1,115,195 | 251.17M |
| 233 | CDNA | CareDx, Inc. | 2.46B | 8.68% | 2,426,285 | 458.09M |
| 234 | NRIX | Nurix Therapeutics, Inc. | 2.40B | -0.26% | 810,981 | 36.77M |
| 235 | VCEL | Vericel Corporation | 2.39B | 1.65% | 316,715 | 306.30M |
| 236 | NKTR | Nektar Therapeutics | 2.39B | 0.11% | 462,565 | 55.63M |
| 237 | LMAT | LeMaitre Vascular, Inc. | 2.37B | 2.21% | 267,624 | 256.28M |
| 238 | PGEN | Precigen, Inc. | 2.36B | 5.74% | 6,151,667 | 31.60M |
| 239 | HTFL | HeartFlow, Inc. | 2.33B | 7.04% | 569,895 | 191.42M |
| 240 | VERA | Vera Therapeutics, Inc. | 2.32B | 0.84% | 1,227,241 | - |
| 241 | MLYS | Mineralys Therapeutics, Inc. | 2.29B | 1.57% | 768,104 | - |
| 242 | CLOV | Clover Health Investments, Corp. | 2.26B | 3.00% | 2,917,960 | 2.21B |
| 243 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.25B | -0.34% | 1,176,758 | -665.00K |
| 244 | PHVS | Pharvaris N.V. | 2.25B | -1.29% | 197,656 | - |
| 245 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.24B | -1.67% | 2,542,653 | 885.72M |
| 246 | KLRA | Kailera Therapeutics, Inc. | 2.24B | 2.13% | 249,912 | - |
| 247 | SION | Sionna Therapeutics, Inc. | 2.23B | 4.77% | 449,890 | - |
| 248 | SLS | SELLAS Life Sciences Group, Inc. | 2.20B | 11.79% | 6,064,110 | - |
| 249 | BFLY | Butterfly Network, Inc. | 2.20B | 16.10% | 11,252,720 | 112.14M |
| 250 | NUVB | Nuvation Bio Inc. | 2.17B | -1.74% | 4,219,329 | 143.05M |
| 251 | ADUS | Addus HomeCare Corporation | 2.14B | 1.16% | 151,447 | 1.45B |
| 252 | VRDN | Viridian Therapeutics, Inc. | 2.12B | 1.32% | 1,342,100 | 70.92M |
| 253 | MD | Pediatrix Medical Group, Inc. | 2.11B | -0.68% | 451,189 | 1.93B |
| 254 | COAG | Hemab Therapeutics Holdings, Inc. | 2.10B | -5.29% | 594,009 | - |
| 255 | AVAH | Aveanna Healthcare Holdings Inc. | 2.10B | 2.66% | 1,261,234 | 2.52B |
| 256 | SGRY | Surgery Partners, Inc. | 2.07B | 3.83% | 885,442 | 3.34B |
| 257 | UFPT | UFP Technologies, Inc. | 2.07B | 4.77% | 142,359 | 608.85M |
| 258 | HRMY | Harmony Biosciences Holdings, Inc. | 2.06B | 0.91% | 576,483 | 899.11M |
| 259 | ZLAB | Zai Lab Limited | 2.04B | -0.44% | 244,162 | 453.28M |
| 260 | NEO | NeoGenomics, Inc. | 2.04B | 3.99% | 2,087,516 | 766.30M |
| 261 | BHVN | Biohaven Ltd. | 2.03B | -0.22% | 1,173,537 | - |
| 262 | WGS | GeneDx Holdings Corp. | 2.02B | 4.55% | 1,002,302 | 442.68M |
| 263 | ADMA | ADMA Biologics, Inc. | 2.02B | 2.96% | 1,928,380 | 509.86M |
| 264 | PVLA | Palvella Therapeutics, Inc. | 2.02B | 1.06% | 111,956 | - |
| 265 | HCM | HUTCHMED (China) Limited | 1.99B | 3.86% | 73,070 | 549.12M |
| 266 | NBTX | Nanobiotix S.A. | 1.97B | 1.47% | 148,260 | 38.27M |
| 267 | ZBIO | Zenas BioPharma, Inc. | 1.97B | -0.83% | 324,973 | 10.00M |
| 268 | ATRC | AtriCure, Inc. | 1.96B | 2.29% | 874,494 | 569.62M |
| 269 | RAPP | Rapport Therapeutics, Inc. | 1.95B | -0.41% | 227,491 | 20.00M |
| 270 | GHRS | GH Research PLC | 1.93B | 0.25% | 183,307 | - |
| 271 | IOVA | Iovance Biotherapeutics, Inc. | 1.92B | 5.41% | 11,461,893 | 285.61M |
| 272 | TYRA | Tyra Biosciences, Inc. | 1.92B | 1.02% | 374,538 | - |
| 273 | URGN | UroGen Pharma Ltd. | 1.91B | 2.77% | 674,878 | 140.49M |
| 274 | SNDA | Sonida Senior Living, Inc. | 1.90B | 0.69% | 266,518 | 367.34M |
| 275 | AUPH | Aurinia Pharmaceuticals Inc. | 1.89B | -1.41% | 1,107,478 | 298.30M |
| 276 | FBRX | Forte Biosciences, Inc. | 1.87B | 0.04% | 539,316 | - |
| 277 | TSHA | Taysha Gene Therapies, Inc. | 1.85B | -1.19% | 1,386,969 | 7.47M |
| 278 | ALMR | Alamar Biosciences, Inc. | 1.85B | 5.21% | 122,172 | 87.16M |
| 279 | MESO | Mesoblast Limited | 1.85B | 2.19% | 204,503 | 65.38M |
| 280 | OCUL | Ocular Therapeutix, Inc. | 1.83B | 2.33% | 2,567,498 | 52.06M |
| 281 | STOK | Stoke Therapeutics, Inc. | 1.83B | 1.70% | 406,920 | 32.08M |
| 282 | AGIO | Agios Pharmaceuticals, Inc. | 1.83B | 1.93% | 881,166 | 98.34M |
| 283 | GENB | Generate Biomedicines, Inc. | 1.82B | 1.50% | 211,061 | 30.30M |
| 284 | ENOV | Enovis Corporation | 1.81B | 7.65% | 1,253,807 | 2.28B |
| 285 | FTRE | Fortrea Holdings Inc. | 1.80B | -1.04% | 2,656,410 | 2.68B |
| 286 | ABCL | AbCellera Biologics Inc. | 1.78B | 2.36% | 3,079,935 | 79.21M |
| 287 | KARD | Kardigan, Inc. | 1.78B | -4.18% | 149,089 | - |
| 288 | LKFT | Lakefront Biotherapeutics NV | 1.78B | -1.87% | 179,792 | 1.20B |
| 289 | NVCR | NovoCure Limited | 1.78B | 2.76% | 1,164,425 | 699.19M |
| 290 | DMRA | Damora Therapeutics, Inc. | 1.76B | -1.24% | 128,190 | - |
| 291 | SNDX | Syndax Pharmaceuticals, Inc. | 1.70B | 1.00% | 1,101,115 | 217.17M |
| 292 | BCAX | Bicara Therapeutics Inc. | 1.70B | -4.32% | 273,805 | - |
| 293 | OMCL | Omnicell, Inc. | 1.70B | 5.88% | 866,319 | 1.25B |
| 294 | ANIP | ANI Pharmaceuticals, Inc. | 1.69B | 0.71% | 302,719 | 923.71M |
| 295 | RXRX | Recursion Pharmaceuticals, Inc. | 1.68B | 5.50% | 12,929,961 | 66.41M |
| 296 | SRPT | Sarepta Therapeutics, Inc. | 1.67B | 6.26% | 2,642,537 | 2.18B |
| 297 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.66B | -2.28% | 1,707,193 | 204.73M |
| 298 | IMCR | Immunocore Holdings plc | 1.65B | -3.96% | 515,600 | 412.81M |
| 299 | TRLV | Trulieve Cannabis Corp. | 1.65B | -0.92% | 529,774 | 1.17B |
| 300 | ASTH | Astrana Health, Inc. | 1.62B | 1.10% | 211,425 | 3.53B |
| 301 | TRAX | First Tracks Biotherapeutics, Inc. | 1.61B | 5.00% | 190,366 | - |
| 302 | HCSG | Healthcare Services Group, Inc. | 1.60B | 0.26% | 330,122 | 1.86B |
| 303 | ANAB | AnaptysBio, Inc. | 1.59B | 0.67% | 172,813 | 232.39M |
| 304 | SEPN | Septerna, Inc. | 1.58B | 1.81% | 147,494 | 72.26M |
| 305 | AGL | agilon health, inc. | 1.57B | 2.97% | 228,736 | 5.82B |
| 306 | BLFS | BioLife Solutions, Inc. | 1.57B | 2.78% | 440,319 | 101.66M |
| 307 | ZYME | Zymeworks Inc. | 1.57B | -0.27% | 274,827 | 81.26M |
| 308 | ATEC | Alphatec Holdings, Inc. | 1.56B | 6.62% | 3,794,814 | 787.08M |
| 309 | CNMD | CONMED Corporation | 1.55B | 11.88% | 1,006,231 | 1.37B |
| 310 | ARDT | Ardent Health, Inc. | 1.54B | 0.75% | 320,664 | 6.43B |
| 311 | INVA | Innoviva, Inc. | 1.53B | -0.86% | 552,734 | 420.69M |
| 312 | AAPG | Ascentage Pharma Group International | 1.53B | -2.90% | 13,734 | 82.08M |
| 313 | CMPS | COMPASS Pathways plc | 1.52B | -0.62% | 2,508,727 | - |
| 314 | INNV | InnovAge Holding Corp. | 1.52B | -1.32% | 273,372 | 949.17M |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.51B | 1.56% | 204,740 | 20.00M |
| 316 | NTLA | Intellia Therapeutics, Inc. | 1.51B | 1.03% | 2,509,944 | 66.09M |
| 317 | INSP | Inspire Medical Systems, Inc. | 1.51B | 4.10% | 613,621 | 915.25M |
| 318 | PAHC | Phibro Animal Health Corporation | 1.50B | 2.04% | 216,059 | 1.50B |
| 319 | VIR | Vir Biotechnology, Inc. | 1.50B | 2.54% | 872,897 | 65.50M |
| 320 | PRGO | Perrigo Company plc | 1.48B | 5.44% | 2,223,965 | 4.18B |
| 321 | XERS | Xeris Biopharma Holdings, Inc. | 1.47B | 0.12% | 1,225,670 | 314.85M |
| 322 | HROW | Harrow, Inc. | 1.44B | -0.15% | 284,683 | 268.68M |
| 323 | MLTX | MoonLake Immunotherapeutics | 1.44B | -5.53% | 1,032,666 | - |
| 324 | XNCR | Xencor, Inc. | 1.43B | -4.26% | 503,107 | 97.36M |
| 325 | AHCO | AdaptHealth Corp. | 1.43B | -0.28% | 1,223,298 | 3.29B |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.41B | 5.26% | 283,278 | 95.13M |
| 327 | PNTG | The Pennant Group, Inc. | 1.41B | 0.42% | 156,565 | 1.02B |
| 328 | IART | Integra LifeSciences Holdings Corporation | 1.39B | 7.27% | 898,983 | 1.65B |
| 329 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -0.13% | 207,708 | - |
| 330 | PSNL | Personalis, Inc. | 1.39B | 4.58% | 2,365,070 | 64.52M |
| 331 | AZTA | Azenta, Inc. | 1.38B | 6.65% | 877,642 | 596.48M |
| 332 | TNDM | Tandem Diabetes Care, Inc. | 1.38B | 2.97% | 2,835,329 | 1.03B |
| 333 | SVRA | Savara Inc. | 1.36B | -2.01% | 1,221,135 | - |
| 334 | ALVO | Alvotech | 1.35B | -8.01% | 920,275 | 562.04M |
| 335 | ABSI | Absci Corporation | 1.34B | 1.93% | 1,503,065 | 1.84M |
| 336 | AORT | Artivion, Inc. | 1.34B | 2.65% | 514,249 | 458.69M |
| 337 | GLUE | Monte Rosa Therapeutics, Inc. | 1.29B | -7.45% | 1,822,205 | 42.95M |
| 338 | AMN | AMN Healthcare Services, Inc. | 1.28B | -1.87% | 666,831 | 3.42B |
| 339 | AVLN | Avalyn Pharma Inc. | 1.28B | -0.05% | 87,095 | - |
| 340 | CERT | Certara, Inc. | 1.27B | 0.74% | 2,493,147 | 419.75M |
| 341 | FRNM | Freenome, Inc. | 1.26B | -0.18% | 724,075 | 34.24M |
| 342 | LBRX | LB Pharmaceuticals Inc | 1.25B | 8.81% | 760,949 | - |
| 343 | ETON | Eton Pharmaceuticals, Inc. | 1.24B | -2.31% | 362,384 | 86.93M |
| 344 | IMTX | Immatics N.V. | 1.23B | 4.27% | 187,576 | 43.00M |
| 345 | ARDX | Ardelyx, Inc. | 1.23B | 0.61% | 2,212,158 | 427.68M |
| 346 | MNKD | MannKind Corporation | 1.22B | -2.30% | 4,045,016 | 360.78M |
| 347 | NVAX | Novavax, Inc. | 1.22B | 1.23% | 1,907,389 | 596.34M |
| 348 | AKTS | Aktis Oncology, Inc. | 1.21B | -0.52% | 227,575 | 8.28M |
| 349 | TDOC | Teladoc Health, Inc. | 1.21B | -0.60% | 5,251,190 | 2.49B |
| 350 | OMDA | Omada Health, Inc. | 1.21B | 2.67% | 638,369 | 283.30M |
| 351 | INBX | Inhibrx Biosciences, Inc. | 1.21B | 0.56% | 112,048 | 1.30M |
| 352 | STAA | STAAR Surgical Company | 1.21B | -0.45% | 828,791 | 290.38M |
| 353 | QDEL | QuidelOrtho Corporation | 1.20B | 5.07% | 931,123 | 2.66B |
| 354 | USPH | U.S. Physical Therapy, Inc. | 1.20B | -0.48% | 168,523 | 787.69M |
| 355 | IRMD | IRADIMED CORPORATION | 1.17B | 0.79% | 179,187 | 86.34M |
| 356 | VOR | Vor Biopharma Inc. | 1.16B | 1.42% | 599,580 | - |
| 357 | AHG | Akso Health Group | 1.16B | -14.01% | 5,372 | 13.83M |
| 358 | COLL | Collegium Pharmaceutical, Inc. | 1.15B | 0.10% | 261,071 | 796.33M |
| 359 | JBIO | Jade Biosciences, Inc. | 1.14B | -2.73% | 516,771 | - |
| 360 | SDGR | Schrödinger, Inc. | 1.14B | 0.79% | 718,795 | 254.91M |
| 361 | WVE | Wave Life Sciences Ltd. | 1.13B | 4.54% | 2,650,317 | 65.37M |
| 362 | CRVS | Corvus Pharmaceuticals, Inc. | 1.13B | 1.06% | 386,292 | - |
| 363 | BVS | Bioventus Inc. | 1.12B | 2.20% | 965,099 | 576.30M |
| 364 | ORIC | ORIC Pharmaceuticals, Inc. | 1.10B | -3.88% | 1,862,663 | - |
| 365 | MGTX | MeiraGTx Holdings plc | 1.10B | 0.81% | 355,197 | 79.76M |
| 366 | SPTX | Seaport Therapeutics, Inc. | 1.10B | 0.29% | 106,736 | - |
| 367 | DRTS | Alpha Tau Medical Ltd. | 1.08B | 1.02% | 298,628 | - |
| 368 | GDRX | GoodRx Holdings, Inc. | 1.07B | 2.93% | 636,101 | 787.89M |
| 369 | LMRI | Lumexa Imaging Holdings, Inc. | 1.06B | 6.29% | 347,737 | 1.03B |
| 370 | ANRO | Alto Neuroscience, Inc. | 1.06B | 0.61% | 296,060 | - |
| 371 | PCRX | Pacira BioSciences, Inc. | 1.05B | 1.51% | 941,099 | 734.86M |
| 372 | CRON | Cronos Group Inc. | 1.05B | 0.18% | 862,891 | 159.54M |
| 373 | PRCT | PROCEPT BioRobotics Corporation | 1.04B | -1.45% | 2,389,013 | 322.02M |
| 374 | EYPT | EyePoint, Inc. | 1.04B | 1.31% | 1,098,482 | 7.61M |
| 375 | NUTX | Nutex Health Inc. | 1.04B | 2.44% | 99,482 | 879.95M |
| 376 | IVA | Inventiva S.A. | 1.03B | -4.80% | 921,136 | 7.94M |
| 377 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | 0.65% | 1,472,979 | 69.64M |
| 378 | GMRS | GMR Solutions Inc. | 1.02B | 1.59% | 259,710 | 5.83B |
| 379 | REPL | Replimune Group, Inc. | 1.00B | 6.83% | 9,107,263 | - |
| 380 | CGEM | Cullinan Therapeutics, Inc. | 1.00B | -1.15% | 254,537 | - |
| 381 | APMD | Apnimed, Inc. | 994.58M | -0.10% | 656,985 | 120.15M |
| 382 | OLMA | Olema Pharmaceuticals, Inc. | 986.15M | -1.40% | 484,115 | - |
| 383 | OPK | OPKO Health, Inc. | 985.15M | - | 3,814,816 | 587.90M |
| 384 | SANA | Sana Biotechnology, Inc. | 956.68M | 1.92% | 1,272,050 | - |
| 385 | AVTX | Avalo Therapeutics, Inc. | 952.25M | -1.37% | 361,695 | 59.00K |
| 386 | JANX | Janux Therapeutics, Inc. | 936.72M | 1.25% | 419,191 | 13.73M |
| 387 | CSTL | Castle Biosciences, Inc. | 934.20M | 9.21% | 612,469 | 357.28M |
| 388 | OMER | Omeros Corporation | 909.03M | 6.08% | 1,073,337 | 9.89M |
| 389 | AMPH | Amphastar Pharmaceuticals, Inc. | 889.35M | 1.15% | 292,444 | 720.53M |
| 390 | INMD | InMode Ltd. | 882.33M | 1.39% | 277,817 | 374.64M |
| 391 | TBPH | Theravance Biopharma, Inc. | 874.34M | 0.06% | 312,754 | 109.78M |
| 392 | TALK | Talkspace, Inc. | 873.58M | -0.10% | 1,050,601 | 238.37M |
| 393 | ODTX | Odyssey Therapeutics, Inc. | 870.90M | -3.91% | 110,884 | 1.06M |
| 394 | GLAS | Glass House Brands Inc. | 862.34M | 5.67% | 496,962 | 177.68M |
| 395 | ANNX | Annexon, Inc. | 860.99M | 3.14% | 1,031,826 | - |
| 396 | ABUS | Arbutus Biopharma Corporation | 859.29M | 0.23% | 1,110,016 | 191.45M |
| 397 | HSTM | HealthStream, Inc. | 830.59M | 1.39% | 92,187 | 311.78M |
| 398 | TENX | Tenax Therapeutics, Inc. | 821.42M | 4.67% | 1,797,052 | - |
| 399 | GERN | Geron Corporation | 817.94M | -1.16% | 17,309,409 | 196.12M |
| 400 | KURA | Kura Oncology, Inc. | 812.29M | 1.55% | 795,849 | 71.64M |
| 401 | SIBN | SI-BONE, Inc. | 811.59M | 3.04% | 567,774 | 206.22M |
| 402 | AVR | Anteris Technologies Global Corp. | 807.91M | 5.74% | 1,195,133 | 1.85M |
| 403 | DSGN | Design Therapeutics, Inc. | 793.20M | 4.27% | 386,345 | - |
| 404 | SLDB | Solid Biosciences Inc. | 792.52M | -0.12% | 651,051 | - |
| 405 | SSII | SS Innovations International, Inc. | 790.52M | -0.75% | 16,444 | 48.47M |
| 406 | DBVT | DBV Technologies S.A. | 789.92M | -0.22% | 272,564 | 5.04M |
| 407 | AURA | Aura Biosciences, Inc. | 775.40M | 0.29% | 344,469 | - |
| 408 | ACRS | Aclaris Therapeutics, Inc. | 769.55M | 5.96% | 1,622,625 | 8.37M |
| 409 | SGP | SpyGlass Pharma, Inc. | 762.78M | 1.26% | 86,002 | - |
| 410 | MNPR | Monopar Therapeutics Inc. | 752.00M | 3.61% | 461,650 | - |
| 411 | CADL | Candel Therapeutics, Inc. | 738.56M | 0.70% | 722,557 | - |
| 412 | IRWD | Ironwood Pharmaceuticals, Inc. | 730.88M | 4.96% | 2,820,815 | 361.51M |
| 413 | DRUG | Bright Minds Biosciences Inc. | 721.25M | 0.46% | 260,495 | - |
| 414 | OCS | Oculis Holding AG | 719.22M | 5.31% | 243,714 | 1.40M |
| 415 | PHAR | Pharming Group N.V. | 718.94M | -1.98% | 30,617 | 366.48M |
| 416 | PHAT | Phathom Pharmaceuticals, Inc. | 714.08M | 2.74% | 1,221,048 | 239.66M |
| 417 | EVO | Evotec SE | 713.37M | 2.61% | 74,323 | 859.03M |
| 418 | CBLL | CeriBell, Inc. | 700.42M | 4.35% | 395,176 | 95.07M |
| 419 | PHR | Phreesia, Inc. | 696.62M | 5.03% | 729,247 | 495.59M |
| 420 | NVCT | Nuvectis Pharma, Inc. | 695.45M | 2.51% | 168,599 | - |
| 421 | RIGL | Rigel Pharmaceuticals, Inc. | 685.87M | 0.71% | 111,276 | 299.77M |
| 422 | CTMX | CytomX Therapeutics, Inc. | 684.68M | 1.45% | 1,575,853 | 35.54M |
| 423 | CLYM | Climb Bio, Inc. | 679.11M | -0.34% | 571,745 | - |
| 424 | GYRE | Gyre Therapeutics, Inc. | 675.62M | 5.39% | 33,525 | 117.05M |
| 425 | TCMD | Tactile Systems Technology, Inc. | 669.47M | 5.36% | 99,956 | 343.52M |
| 426 | FTH | Faeth Therapeutics, Inc. | 659.03M | -6.15% | 258,782 | - |
| 427 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 657.68M | 1.48% | 154,164 | - |
| 428 | NGNE | Neurogene Inc. | 651.41M | -0.61% | 115,309 | 925.00K |
| 429 | AGMB | AgomAb Therapeutics NV | 651.06M | 2.72% | 123,737 | - |
| 430 | ACHV | Achieve Life Sciences, Inc. | 649.83M | -1.40% | 720,641 | - |
| 431 | CBIO | Crescent Biopharma, Inc. | 636.88M | 2.83% | 173,907 | 11.88M |
| 432 | ALLO | Allogene Therapeutics, Inc. | 633.36M | -2.39% | 6,024,491 | 22.00K |
| 433 | ANGO | AngioDynamics, Inc. | 629.08M | 2.91% | 629,210 | 320.17M |
| 434 | TLRY | Tilray Brands, Inc. | 628.57M | 2.09% | 5,597,138 | 915.45M |
| 435 | BWAY | BrainsWay Ltd. | 624.59M | 3.74% | 75,655 | 56.22M |
| 436 | MDXG | MiMedx Group, Inc. | 623.85M | 3.63% | 1,423,514 | 355.17M |
| 437 | RGNX | REGENXBIO Inc. | 613.33M | 2.58% | 597,551 | 87.82M |
| 438 | BBNX | Beta Bionics, Inc. | 610.96M | 5.85% | 2,336,362 | 119.01M |
| 439 | CTNM | Contineum Therapeutics, Inc. | 609.84M | 4.65% | 247,144 | - |
| 440 | IMMX | Immix Biopharma, Inc. | 596.57M | 0.72% | 1,417,991 | - |
| 441 | ZVRA | Zevra Therapeutics, Inc. | 592.92M | 5.47% | 1,068,485 | 122.29M |
| 442 | CRMD | CorMedix Inc. | 589.17M | -0.27% | 602,650 | 400.05M |
| 443 | DNA | Ginkgo Bioworks Holdings, Inc. | 582.04M | 10.14% | 1,161,157 | 151.40M |
| 444 | ALT | Altimmune, Inc. | 580.51M | 5.11% | 3,793,941 | 36.00K |
| 445 | MPLT | MapLight Therapeutics, Inc. | 574.08M | -2.76% | 825,843 | - |
| 446 | STTK | Shattuck Labs, Inc. | 560.92M | 3.47% | 788,048 | 1.00M |
| 447 | CTKB | Cytek Biosciences, Inc. | 554.67M | 1.78% | 607,202 | 204.17M |
| 448 | RLMD | Relmada Therapeutics, Inc. | 549.62M | -1.32% | 723,155 | - |
| 449 | WEAV | Weave Communications, Inc. | 540.25M | 3.82% | 519,837 | 248.72M |
| 450 | SPRY | ARS Pharmaceuticals, Inc. | 537.23M | 5.46% | 1,601,579 | 98.99M |
| 451 | KIDS | OrthoPediatrics Corp. | 536.94M | 3.54% | 292,597 | 243.30M |
| 452 | FDMT | 4D Molecular Therapeutics, Inc. | 526.42M | -1.08% | 264,403 | 88.24M |
| 453 | ZURA | Zura Bio Limited | 526.29M | 2.03% | 340,622 | - |
| 454 | TECX | Tectonic Therapeutic, Inc. | 525.18M | -0.70% | 77,819 | - |
| 455 | SLBT | SL Science Holding Limited | 523.67M | 22.50% | 192,394 | 3.36M |
| 456 | ARTV | Artiva Biotherapeutics, Inc. | 520.87M | 6.14% | 474,171 | 251.00K |
| 457 | ANL | Adlai Nortye Ltd. | 516.00M | -0.77% | 191,876 | 5.00M |
| 458 | ARVN | Arvinas, Inc. | 514.56M | -0.68% | 494,592 | 89.40M |
| 459 | TOI | The Oncology Institute, Inc. | 510.41M | 5.04% | 966,345 | 545.76M |
| 460 | SLN | Silence Therapeutics plc | 510.13M | 2.96% | 473,117 | 839.00K |
| 461 | RZLT | Rezolute, Inc. | 509.80M | 3.39% | 1,089,801 | - |
| 462 | PRME | Prime Medicine, Inc. | 506.63M | -3.94% | 3,562,834 | 4.03M |
| 463 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 464 | VREX | Varex Imaging Corporation | 503.23M | 6.70% | 354,903 | 857.50M |
| 465 | VSTM | Verastem, Inc. | 500.88M | -1.72% | 896,029 | 49.59M |
| 466 | HELP | Cybin Inc. | 498.97M | 2.94% | 1,056,425 | - |
| 467 | OFIX | Orthofix Medical Inc. | 494.36M | 3.64% | 334,740 | 825.37M |
| 468 | EIKN | Eikon Therapeutics, Inc. | 493.74M | -0.98% | 192,240 | - |
| 469 | NNNN | Anbio Biotechnology | 490.70M | 12.93% | 119,679 | 8.65M |
| 470 | ASMB | Assembly Biosciences, Inc. | 488.40M | 1.04% | 163,412 | 71.10M |
| 471 | SOPH | SOPHiA GENETICS SA | 482.82M | 1.50% | 327,706 | 81.18M |
| 472 | FLGT | Fulgent Genetics, Inc. | 482.34M | 5.92% | 399,340 | 323.93M |
| 473 | AUTL | Autolus Therapeutics plc | 480.39M | 21.14% | 13,135,575 | 92.62M |
| 474 | BIOA | BioAge Labs, Inc. | 478.76M | 19.14% | 3,023,706 | 10.32M |
| 475 | AQST | Aquestive Therapeutics, Inc. | 475.52M | 2.57% | 1,710,727 | 50.27M |
| 476 | PROK | ProKidney Corp. | 474.23M | 1.95% | 499,720 | 889.00K |
| 477 | SRTA | Strata Critical Medical, Inc. | 472.87M | 8.86% | 1,154,390 | 228.58M |
| 478 | VALN | Valneva SE | 468.61M | 2.01% | 6,072 | 180.25M |
| 479 | SI | Shoulder Innovations, Inc. | 468.27M | -0.70% | 44,607 | 53.89M |
| 480 | NPCE | NeuroPace, Inc. | 460.95M | 4.89% | 446,927 | 99.53M |
| 481 | CLPT | ClearPoint Neuro, Inc. | 458.84M | 2.41% | 407,928 | 40.61M |
| 482 | KYTX | Kyverna Therapeutics, Inc. | 457.18M | 3.01% | 646,763 | - |
| 483 | QTTB | Q32 Bio Inc. | 452.26M | -3.09% | 249,612 | 53.74M |
| 484 | DCTH | Delcath Systems, Inc. | 449.82M | 6.63% | 462,428 | 90.44M |
| 485 | VMD | Viemed Healthcare, Inc. | 449.69M | 0.51% | 321,280 | 286.57M |
| 486 | SGMT | Sagimet Biosciences Inc. | 442.14M | 0.70% | 2,761,919 | - |
| 487 | PACB | Pacific Biosciences of California, Inc. | 439.50M | 1.07% | 2,907,290 | 160.03M |
| 488 | CABA | Cabaletta Bio, Inc. | 438.62M | 0.37% | 1,315,643 | - |
| 489 | NRC | NRC Health | 438.14M | 1.44% | 83,121 | 140.00M |
| 490 | PRTA | Prothena Corporation plc | 437.67M | 2.96% | 371,051 | 57.94M |
| 491 | OVID | Ovid Therapeutics Inc. | 435.80M | 5.18% | 1,414,455 | 7.12M |
| 492 | PRLD | Prelude Therapeutics Incorporated | 435.39M | -4.57% | 209,551 | 16.72M |
| 493 | CERS | Cerus Corporation | 435.29M | 0.47% | 3,855,865 | 221.55M |
| 494 | IKT | Inhibikase Therapeutics, Inc. | 432.86M | 1.61% | 363,253 | 1.00 |
| 495 | OCGN | Ocugen, Inc. | 421.46M | 1.22% | 2,506,956 | 4.47M |
| 496 | CTEV | Claritev Corporation | 418.44M | 8.08% | 35,591 | 978.76M |
| 497 | EPRX | Eupraxia Pharmaceuticals Inc. | 418.17M | 0.31% | 74,796 | - |
| 498 | KMDA | Kamada Ltd. | 416.05M | 1.82% | 23,916 | 181.68M |
| 499 | EVMN | Evommune, Inc. | 415.29M | 2.49% | 772,537 | 10.00M |
| 500 | STRO | Sutro Biopharma, Inc. | 415.26M | 3.68% | 139,707 | 99.61M |